THE OVERALL SCOPE OF THIS REQUIREMENT IS TO SUPPORT AND MAINTAIN THE CURRENT ELECTRONIC PATHOLOGY REPORTING INFRASTRUCTURE, INCLUDING MAINTAINING CONT
该要求的总体范围是支持和维护当前的电子病理报告基础设施,包括维护 CONT
基本信息
- 批准号:10291487
- 负责人:
- 金额:$ 80.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-26 至 2023-09-25
- 项目状态:已结题
- 来源:
- 关键词:AutomationBenignBrainCharacteristicsClassificationCodeComputer softwareComputerized Medical RecordDataDiagnosisDiagnosticDiagnostic ImagingDictionaryHealth Insurance Portability and Accountability ActHistopathologyInformation TechnologyInfrastructureLaboratoriesLicensingMalignant - descriptorMalignant NeoplasmsManualsMedicalMethodsOperative Surgical ProceduresPathologyPathology ReportProcessRadiation OncologyRecordsRegistriesReportingSEER ProgramSavingsSecureSiteSourceSystemTerminologyTextTravelbasecancer registrarsdata managementdata registryelectronic dataflexibilityneoplasm registryoperationtransmission process
项目摘要
The overall scope of this requirement is to support and maintain the current electronic pathology reporting
infrastructure, including maintaining continuity of electronic pathology reporting licenses for the
facilities listed in Attachment 2 “SEER ePath Sites” and to install and maintain new license installations
as required by the NCI to support the SEER program.
这项要求的总体范围是支持和维护当前的电子病理报告
基础设施,包括保持电子病理报告许可证的连续性
附件2“SEER ePath站点”中列出的设施以及安装和维护新许可证安装的设施
按照NCI的要求支持SEER计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK LLOYD其他文献
MARK LLOYD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK LLOYD', 18)}}的其他基金
THE OVERALL SCOPE OF THIS REQUIREMENT IS TO SUPPORT AND MAINTAIN THE CURRENT ELECTRONIC PATHOLOGY REPORTING INFRASTRUCTURE, INCLUDING MAINTAINING CONT
该要求的总体范围是支持和维护当前的电子病理报告基础设施,包括维护 CONT
- 批准号:
10706415 - 财政年份:2020
- 资助金额:
$ 80.86万 - 项目类别:
THE OVERALL SCOPE OF THIS REQUIREMENT IS TO SUPPORT AND MAINTAIN THE CURRENT ELECTRONIC PATHOLOGY REPORTING INFRASTRUCTURE, INCLUDING MAINTAINING CONT
该要求的总体范围是支持和维护当前的电子病理报告基础设施,包括维护 CONT
- 批准号:
10352292 - 财政年份:2020
- 资助金额:
$ 80.86万 - 项目类别:
相似海外基金
Genome analysis-based prediction model development for response to stereotactic radiosurgery in benign brain tumors
基于基因组分析的预测模型开发,用于良性脑肿瘤立体定向放射外科治疗的反应
- 批准号:
23K08495 - 财政年份:2023
- 资助金额:
$ 80.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
- 批准号:
10719777 - 财政年份:2023
- 资助金额:
$ 80.86万 - 项目类别:
Environmentally Benign Precise Transformations of Alkenes by Chiral Chalcogenide Catalysts
手性硫属化物催化剂对环境无害的烯烃精确转化
- 批准号:
22KJ2498 - 财政年份:2023
- 资助金额:
$ 80.86万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
良性泌尿外科、良性肾脏病学和非癌症血液学领域的学习者和领导者
- 批准号:
10726042 - 财政年份:2023
- 资助金额:
$ 80.86万 - 项目类别:
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
- 批准号:
10607151 - 财政年份:2023
- 资助金额:
$ 80.86万 - 项目类别:
Development of a medical device to resolve benign esophageal stricture by heating and traction
开发通过加热和牵引解决良性食管狭窄的医疗设备
- 批准号:
23H03765 - 财政年份:2023
- 资助金额:
$ 80.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of benign/malignant differentiation method for thyroid follicular tumor using organoids
利用类器官开发甲状腺滤泡性肿瘤良恶性鉴别方法
- 批准号:
23K08075 - 财政年份:2023
- 资助金额:
$ 80.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis
p53在散发性肿瘤发生良性向恶性转变中的参与和作用机制
- 批准号:
10720034 - 财政年份:2023
- 资助金额:
$ 80.86万 - 项目类别:
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 80.86万 - 项目类别:
Standard Grant
Identifying the role of the gut microbiome in the etiology of benign breast disease
确定肠道微生物组在良性乳腺疾病病因学中的作用
- 批准号:
10359959 - 财政年份:2022
- 资助金额:
$ 80.86万 - 项目类别: